A two-arm randomized open-label prospective design superiority phase III clinical trial to compare the efficacy of docetaxel-oxaliplatin-capecitabine/5 fluorouracil (DOC/F) followed by docetaxel versus CAPOX/mFOLFOX-7 in advanced gastric cancers (DOC-GC study).

被引：0
|
作者：
Ramaswamy, Anant
Bhargava, Prabhat Ghanshyam
Dubashi, Biswajit
Kapoor, Akhil
Srinivas, Sujay
Shetty, Omshree
Kaushal, Rajiv Kumar
Shah, Aekta
Noronha, Vanita
Joshi, Amit
Menon, Nandini Sharrel
Nashikkar, Chaitali
Gupta, Anuj
Mishra, Bal Krishna
Kayal, Smita
Ananthakrishnan, Ramesh
Kumar, Suman
Ganesan, Prasanth
Prabhash, Kumar
Ostwal, Vikas S.
机构：
[1] Tata Mem Hosp HBNI, Mumbai, India
[2] JIPMER, Pondicherry, India
[3] Homi Bhabha Canc Hosp, Varanasi, Uttar Pradesh, India
[4] Tata Mem Hosp, Mumbai, Maharashtra, India
[5] Tata Mem Ctr HBNI, Mumbai, Maharashtra, India
[6] JIPMER, Reg Canc Ctr, Dept Med Oncol, Dhanavantri Nagar, Pondicherry, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
261-492-3532-2370-7650-2700; 261-566-148; 281-318-9082; 4; 3; 256; 54; 1589; 239; 92; 193; 65; 1704; 1700; 2861; 6; 2; 1;
D O I：
10.1200/JCO.2024.42.3_suppl.LBA248
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：247 / 248
页数：2
相关论文
共 1 条
  • [1] A two-arm randomized open-label prospective design superiority phase III clinical trial to compare the efficacy of docetaxel-oxaliplatin-capecitabine/ 5-fluorouracil (DOC/F) followed by docetaxel versus CAPOX/mFOLFOX-7 in advanced gastric cancers
    Bhargava, P. G.
    Ramaswamy, A.
    Dubashi, B.
    Kapoor, A.
    Srinivas, S.
    Shetty, O.
    Kaushal, R.
    Shah, A.
    Noronha, V.
    Joshi, A. P.
    Menon, N. S.
    Nashikkar, C.
    Gupta, A.
    Mishra, B. K.
    Sisodia, N.
    Pal, V.
    Kayal, S.
    Prabhash, K.
    Ostwal, V. S.
    ANNALS OF ONCOLOGY, 2023, 34 : S1554 - S1555
1